Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.
Carl June
CAR T immunotherapy
Madhav Dhodapkar
multiple myeloma immunotherapy
Noemí Puig Morón
Myeloma
Sigurður Kristinsson
Smoldering myeloma
Ricky Johnstone
lymphoma and myeloma
Armin Rashidi
gut bacteria and transplant success
Brian Walker
smoldering myeloma, MGUS
Sham Mailankody
Myeloma immunotherapy clinical trials
Christopher Flowers
clinical trial access
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Urvi Shah
Diet and myeloma
Matteo Bellone
Smoldering multiple myeloma
Peter Croucher
Multiple Myeloma
Jing Fu
myeloma
Caroline Arber
myeloma CAR-T
Qing Yi
Novel CAR-T
Jonathan Licht
DNA biology, myeloma
Ruben Carrasco
Myeloma
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Michaela Reagan
Multiple Myeloma
Suzanne Lentzsch
Myeloma
Alfred Garfall
myeloma immunotherapy
Jing Yang
Myeloma
John Leonard
lymphoma research
Paul Beavis
immunotherapy in myeloma
Robert Orlowski
(Smoldering) Multiple Myeloma
Nizar Bahlis
Myeloma immunotherapy
Bruno Paiva
smoldering myeloma
Lev Kats
myeloma and epigenetics
Simona Colla
Myeloma biology
Eugenio Morelli
Myeloma
William Matsui
Myeloma
Mala Shanmugam
myeloma
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
F. Lennie Wong
Equity in Access
Tanya Siddiqi
clinical trial access
Fenghuang Zhan
Myeloma and bone disease
Siegfried Janz
Myeloma immunotherapy
Jun Qi
Myeloma
Jianhua Yu
myeloma immunotherapy
Lawrence Boise
CART and myeloma